Psychedelic Stocks Just Went Mainstream Submitted by QTR’s Fringe Finance Donald Trump just did something that would have sounded borderline impossible a couple of years ago: he signed an executive order aimed at accelerating research and access to psychedelic therapies, backing it with $50 million in federal funding and directing regulators to remove barriers that have long kept this entire category stuck on the sidelines. This has been a key prediction in my thesis for psychedelic stocks that I’ve laid out over time. First, in January 2025, calling the psychedelic names “stocks to watch” for the year. Then, in July 2025, urging patience in these positions: Being Early—And Patient—In Psychedelics Then again naming psychedelic names to my “stocks to watch” for 2026 and even going so far as to name the sector my “best idea” for 2026: My “Best Idea” Sector For 2026 Today I’ll discuss what, for me, remains the most prudent way to get and keep long-term exposure to the sector, and where I think things go after this morning’s rally. Trump’s administration framed the move as part of a broader attempt to confront the mental health crisis, particularly among veterans, while signaling that agencies like the FDA should dramatically speed up review timelines for promising treatments. The focus, at least initially, includes ibogaine, a compound with a controversial safety profile but growing interest for its potential in treating addiction and trauma. Alongside him were figures like Robert F. Kennedy Jr. and Joe Rogan, both of whom have been outspoken advocates for these therapies, underscoring how quickly this conversation has moved from the fringe into the mainstream. There are still real concerns from scientists about safety, trial rigor, and whether the process could move too fast, but the direction is unmistakable: the federal government is no longer ignoring psychedelics, it is actively engaging with them.

Four years of trading blows with one of the world’s most powerful militaries has come at enormous cost in blood and treasure for Ukraine.

Deutsche Telekom, T-Mobile Weigh Potential Mega-Merger A new Bloomberg report states that Deutsche Telekom AG is exploring a mega merger with its U.S. subsidiary, T-Mobile US, in a move that would create a telecom giant valued at roughly $400 billion. If completed, the deal would rank as the largest public M&A transaction ever. Deutsche Telekom shares fell 4% in Germany on Wednesday morning after Bloomberg reported overnight that the company is in the early stages of considering a combination with T-Mobile US, in which it already holds a 53% stake. Here’s more color from the outlet: The potential deal would create a single, simplified corporate group that controls the operations of Deutsche Telekom and T-Mobile and would be jointly owned by the two companies’ current investors. The combined entity may then seek a listing in the US and a major European exchange, though the details are still being worked out, some of the people said. . . . Discussions are at a preliminary stage and any transaction would require political support to move ahead, the people said. Details of the possible deal could also change. The companies have considered a closer tie-up on-and-off for years, and there’s no certainty they will decide to proceed this time, the people said. Commenting on the report, NewStreet Research analysts told clients earlier that a transatlantic group would provide the companies with “more optionality” to pursue potentially large acquisitions without diluting Deutsche Telekom. “For that alone, we think this is a highly worthwhile deal for DT to consider, as it would give DT more future options in a consolidating marketplace where convergence could take any form over the next 5 to 10 years,” NewStreet Research analysts said, adding that they believe a deal would likely be a “nil-premium merger.” Citigroup analysts are more skeptical: